Immune Targeting Systems ITS Ltd
Immune Targeting Systems Confirms Industry Heavyweight Ken Powell as New Chairman
Published in TB and Outbreaks Week, December 1st, 2009
Immune Targeting Systems (ITS) Ltd, whose synthetic universal influenza-A vaccine enters clinical trials in 2010, announced that Ken Powell has joined the board as non-executive Chairman. Ken was formerly CEO of Arrow Therapeutics which he led to a successful trade sale to Astra-Zeneca in 2007. The Company also announced the appointment of Dr. Campbell Bunce, formerly Development Director at Piramed, as R&D Director.
Immune Targeting Systems is developing vaccines for mutating viruses. The lead candidate (FP-01) is a synthetic vaccine against all potential seasonal and pandemic influenza strains. This will eliminate the need to remanufacture the vaccine each year in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- BioMed Central
Immediate, aggressive spending on HIV/AIDS could end epidemic - Imperial College London
HIV vaccine failure probably caused by virus used, says new research - Arthritis
Studies from University of Western Australia yield new data on arthritis - Life Sciences
Research from Osaka University yields new data on life sciences - Multidrug Resistant Tuberculosis
Findings from C.J. Lavender and co-authors provide new insights into multidrug resistant tuberculosis - Non-Small Cell Lung Cancer
Studies from Yonsei University, Medical Department provide new data on non-small cell lung cancer - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
